Title: Interventional Pulmonology Market Analysis by Top Trends and Growth Opportunities to 2032
1- The global market size for interventional
pulmonology market reached USD 1.36 Billion in
2022 and is projected to attain USD 2.31 Billion
by 2032, exhibiting a robust compound annual
growth rate (CAGR) of 5.3 throughout the
forecast period. The surge in the prevalence of
respiratory ailments, coupled with the growing
demand for minimally invasive procedures and
advancements in interventional pulmonology
technology, stands as key catalysts propelling
the market's revenue expansion. - On a worldwide scale, the incidence of
respiratory diseases such as asthma, lung cancer,
and chronic obstructive pulmonary disease (COPD)
is on the rise, fostering an increased need for
interventional pulmonology interventions.
According to the World Health Organization (WHO),
by 2030, COPD is expected to surpass heart
disease, emerging as the third leading cause of
global mortality. - Request a sample report of Interventional
Pulmonology Market - _at_ https//www.reportsanddata.com/download-free-sam
ple/7363 - The increasing prevalence of respiratory
illnesses due to an aging population and high
smoking rates is anticipated to bolster market
revenue growth. Minimally invasive procedures, in
comparison to more conventional surgical
treatments, are associated with lower levels of
pain, shorter hospital stays, and a reduced risk
of complications. Moreover, advancements in
interventional pulmonology technology play a
pivotal role in driving market revenue growth.
The precision and safety of interventional
pulmonology procedures have seen improvements
through developments in navigation systems,
diagnostic imaging, and bronchoscopy. The
progression of robotic-assisted bronchoscopy
further enhances the accuracy and effectiveness
of interventional pulmonology procedures. - Furthermore, healthcare costs and government
initiatives to promote the use of interventional
pulmonology procedures are also expected to drive
market revenue growth during the forecast period.
Governments worldwide are investing in healthcare
infrastructure and advocating for the adoption of
state-of-the-art medical technologies to enhance
patient outcomes. For instance, the National Lung
Screening Trial (NLST) in the U.S. recommended
low-dose Computed Tomography (CT) screening for
lung cancer, consequently increasing the demand
for interventional pulmonology procedures. - Some Key Highlights from the Report
- Bronchoscopy is the most often used
interventional pulmonary method, followed by
thoracoscopy and pleuroscopy. Bronchoscopy
involves inserting a short, flexible tube called
a Bronchoscope through the mouth or nose and into
the lungs to identify and treat different lung
illnesses. It is commonly used in the diagnosis
of lung cancer, chronic obstructive pulmonary
disease (COPD), and other respiratory disorders.
Bronchoscopy will account for the largest revenue
share of the interventional pulmonology market in
2022. In addition to advancements in bronchoscopy
technology and methods, increased lung disease
prevalence is expected to drive market growth in
the coming years. - The lung cancer segment accounted for a large
revenue share of the global interventional
pulmonology market in 2022. According to the
World Health Organization (WHO), lung cancer is
the leading cause of cancer-related deaths
worldwide, with more than 1.8 million deaths
expected in 2020. Interventional pulmonology
employs a minimally invasive technique for the
detection and treatment of lung cancer, which
involves bronchoscopy for biopsy, endobronchial
Ultrasound-guided transbronchial needle
aspiration (EBUS-TBNA) for staging, and airway
stent
2- implantation for palliative care. The rising
prevalence of lung cancer and the increasing
adoption of minimally invasive procedures for its
diagnosis and treatment are expected to drive
revenue growth in the interventional pulmonology
market. - The North American region is expected to have a
dominant market share for interventional
pulmonology during the forecast period. The
increasing prevalence of lung illnesses and the
increased need for less invasive procedures are
the primary factors impacting market expansion in
this area. Furthermore, the area is home to some
of the finest interventional pulmonology clinics
and has a well-established healthcare
infrastructure. Adoption of cutting-edge
technology and increased RD expenditures are
also driving the market in this sector. - Key Players covered in this report are
- Boston Scientific Corporation
- Cook Group Incorporated
- Olympus Corporation
- Medtronic
- Johnson Johnson
- Fujifilm Holdings Corporation
- Endo International plc
- Stryker Corporation
- BD (Becton, Dickinson and Company)
- Teleflex Incorporated
- Procedure Type Outlook (Revenue, USD Billion
2022 - 2032) - Bronchoscopy
- Thoracoscopy
- Pleuroscopy
- Tracheobronchial Stent Placement
- Others
3- Read the full report _at_ https//www.reportsanddata.
com/report-detail/interventional-pulmonology-
market - Based on Region market is segmented into
- North America
- Europe
- Asia-Pacific
- South America
- Middle East Africa
- Major Points covered in this report are as below
- An analysis of Interventional Pulmonology
industry development trends and marketing
channels, as well as an assessment of the
feasibility of new investment projects, is
presented in the study. - In addition to providing key statistics on the
industry, the report provides valuable guidance
and direction for companies and individuals
interested in this market through tables and
figures. - In addition to developing policies and plans,
this report analyzes manufacturing processes and
cost structures. It also provides information
about import/export demand, costs, prices,
revenues, and gross margins. - This report provides information on the market
status of Interventional Pulmonology
manufacturers and provides valuable insight into
the market for companies and individuals. - Request a customization of the report _at_
https//www.reportsanddata.com/request-customizati
on- form/7363 - We can also provide the customized data for
separate regions like North America, United
States, Canada, Mexico, Asia-Pacific, China,
India, Japan, South Korea, Australia, Indonesia,
Singapore, Rest of Asia-Pacific, Europe, Germany,
France, UK, Italy, Spain, Russia, Rest of Europe,
Central South America, Brazil, Argentina, Rest
of South America, Middle East Africa, Saudi
Arabia, Turkey, Rest of Middle East - Africa
- Browse More Reports
- Disposable Nursing Pad Market _at_
https//www.reportsanddata.com/report-detail/dispo
sable-nursing- pad-market - Zinc Pyrithione Market _at_ https//www.reportsanddat
a.com/report-detail/zinc-pyrithione-market Pest
Control Market _at_ https//www.reportsanddata.com/re
port-detail/pest-control-market - Ink Resins Market _at_ https//www.reportsanddata.com
/report-detail/ink-resins-market
4About Reports and Data Reports and Data is a
market research and consulting company that
provides syndicated research reports, customized
research reports, and consulting services. Our
solutions purely focus on your purpose to locate,
target and analyze consumer behavior shifts
across demographics, across industries and help
clients make a smarter business decision. We
offer market intelligence studies ensuring
relevant and fact-based research across a
multiple industries including Healthcare,
Technology, Chemicals, Power and Energy. We
consistently update our research offerings to
ensure our clients are aware about the latest
trends existent in the market. Reports and Data
has a strong base of experienced analysts from
varied areas of expertise. Contact Us John
W (Head of Business Development) Reports and Data
Web www.reportsanddata.com Direct Line
1-212-710-1370 E-mail sales_at_reportsanddata.com B
logs Press Release Industry News Our
competencies Browse More Upcoming Reports _at_
https//www.reportsanddata.com/upcoming-reports Br
owse More Latest Reports _at_ https//www.reportsandd
ata.com/report